dalteparin has been researched along with Bone Cancer in 3 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miller, RE | 1 |
| Jones, JC | 1 |
| Tometsko, M | 1 |
| Blake, ML | 1 |
| Dougall, WC | 1 |
| Liu, CY | 1 |
| Yim, BT | 1 |
| Wozniak, AJ | 1 |
| Olsson, E | 1 |
| Svartling, N | 1 |
| Asko-Seljavaara, S | 1 |
| Lassila, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Remote Ischemic Preconditioning in Head and Neck Cancer Reconstruction - A Randomized Controlled Trial[NCT02548377] | 60 participants (Actual) | Interventional | 2015-09-29 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for dalteparin and Bone Cancer
| Article | Year |
|---|---|
Activation of coagulation and fibrinolysis during reconstructive microsurgery in patients with cancer.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Blood Coagulation; Bone Neoplasms; Dalteparin; | 2001 |
2 other studies available for dalteparin and Bone Cancer
| Article | Year |
|---|---|
RANKL inhibition blocks osteolytic lesions and reduces skeletal tumor burden in models of non-small-cell lung cancer bone metastases.
Topics: Animals; Anticoagulants; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Enoxaparin; Female; Humans; | 2014 |
Anticoagulation therapy for radiation-induced myelopathy.
Topics: Anticoagulants; Bone Neoplasms; Enoxaparin; Female; Humans; Lung Neoplasms; Middle Aged; Muscular Di | 2001 |